One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 180,000 shares of Pfizer Inc. (NYSE: PFE) on Tuesday, as the price of this fund was down over 1% in the day’s session. However, it is up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 187,746 shares of Pfizer. At Tuesday’s closing price, this would have valued this purchase at roughly $8.8 million. This is only a small fraction of the total holdings. The fund is up about 54% over the past 52 weeks.
Check out all the ARK Invest buys for Tuesday:
|ARKQ||SPFR||JAWS SPITFIRE ACQUISITION||14,101|
|ARKW||KVSB||KHOSLA VENTURES ACQUISITION II||235,181|
|ARKX||BLDE||BLADE AIR MOBILITY||11,216|
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.